Cytarabine | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Cytarabine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

29 API Suppliers, 15 USDMF, 5 CEP/COS, 2 JDMF, 2 EU WC, 1 KDMF, 4 NDC API, 13 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

68 Drugs in Development

68 Drugs in Development

FINISHED DOSAGE FORMULATIONS

118 FDF Dossiers, 31 FDA Orange Book, 37 Europe, 4 Canada, 2 Australia, 10 South Africa, 34 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 DKSH, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 5 Actylis, 1 Finar, 1 Gangwal Chemicals, 4 Nippon Fine Chemical

EXCIPIENTS BY APPLICATIONS

7 Parenteral, 5 Topical, 3 Thickeners and Stabilizers, 2 Taste Masking, 2 Coating Systems & Additives, 2 Solubilizers, 2 Surfactant & Foaming Agents, 2 Emulsifying Agents, 1 Film Formers & Plasticizers, 1 Co-Processed Excipients

DIGITAL CONTENT

53 News #PharmaBuzz

53 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 26 Regulatory FDF Prices, 5 Annual Reports

MARKET PLACE

6 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents, 1 US Exclusivities

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 1 Others

$ Xls

Filters

Filters

FILTER :

filter Company Name Reset all filters

1 All

01 1CELATOR PHARMS

filter Product Reset all filters

filter Exclusivity Expiration Date Reset all filters

filter Exclusivity Code Reset all filters

Product Main Page

01

CELATOR PHARMS

CYTARABINE; DAUNORUBICIN

Cancer Research

Not Confirmed

Contact us
to update this info